CN117679350A - Guaiac composition for removing acne marks and smoothing acne pits and application thereof - Google Patents

Guaiac composition for removing acne marks and smoothing acne pits and application thereof Download PDF

Info

Publication number
CN117679350A
CN117679350A CN202311720109.8A CN202311720109A CN117679350A CN 117679350 A CN117679350 A CN 117679350A CN 202311720109 A CN202311720109 A CN 202311720109A CN 117679350 A CN117679350 A CN 117679350A
Authority
CN
China
Prior art keywords
guaiac
composition
extract
parts
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202311720109.8A
Other languages
Chinese (zh)
Other versions
CN117679350B (en
Inventor
张建华
刘世超
郭文姣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nord Traceability Guangzhou Biotechnology Co ltd
Original Assignee
Nord Traceability Guangzhou Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nord Traceability Guangzhou Biotechnology Co ltd filed Critical Nord Traceability Guangzhou Biotechnology Co ltd
Priority to CN202311720109.8A priority Critical patent/CN117679350B/en
Publication of CN117679350A publication Critical patent/CN117679350A/en
Application granted granted Critical
Publication of CN117679350B publication Critical patent/CN117679350B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9711Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a guaiac composition for fading acne marks and smoothing acne pits and application thereof, and belongs to the technical field of cosmetics; the guaiac composition provided by the invention comprises the following components in parts by mass: 0.2-10 parts of onion extract, 0.1-2 parts of plant ecdysteroid, 0.1-5 parts of guaiacum extract, 0.1-2 parts of VC derivative and 0.1-1 part of light black giant seaweed extract. The guaiac composition provided by the invention has the effects of removing red and black acne marks, smoothing acne pits, improving pigmentation, refining pores and relieving and stabilizing; in addition, the guaiac composition provided by the invention is mild and non-irritating in whole, and can prevent acne recurrence; the guaiac composition can be applied to cosmetics to improve skin qualification and improve skin texture. Meanwhile, the guaiac composition provided by the invention has natural component sources, and the preparation method is simple and suitable for actual production.

Description

Guaiac composition for removing acne marks and smoothing acne pits and application thereof
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a guaiac composition for fading acne marks and smoothening acne pits and application thereof.
Background
Acne marks, pits, and sensitive skin barrier conditions remain behind after acne, which are of greater concern to the patient than acne. Regardless of the location of the pigmentation, if the underlying factors are not adequately controlled, the pigments darken or spread, which is often long-term and recurrent, potentially causing skin color changes and psychological damage to the patient. Acne patients are prone to pigmentation and tissue damage, and in the early stages the skin is reddish, which is associated with the continued presence of inflammation after resolution of the acne, leading to vasodilation and the presence of red spots in the high tide and resolution phases of inflammation development. The black acne marks are pigmentation caused after inflammation, inflammatory factors stimulate melanocytes and induce melanocytes to synthesize and transport melanin to surrounding keratinocytes, darkening the skin exterior, which may also be permanent. In addition, during inflammation, inflammatory cells secrete degrading enzymes, decompose collagen, elastin, hyaluronic acid and other tissues in dermis, cause dermis injury and thus make skin dent, and form acne pits; at the same time, the residue of the acne marks and the acne pits is also often accompanied by the skin problem of large pores.
In the prior art, a plurality of acne-removing products exist, such as natural components from some sources, such as plant extracts, have the characteristics of anti-inflammatory, bacteriostasis and repairing, but the existing plant extract raw materials or products have weak pertinence to acne marks, especially the repairing effect on acne pits is incomplete and not ideal, and the problem of large pores caused by the existence of the acne marks and the acne pits cannot be solved. Meanwhile, the skin damage problem left after acne is ignored in the prior art, the skin barrier is in a sensitive fragile state after acne for a long time, some products are complex in built-in components and contain acid substances such as azelaic acid, salicylic acid, fruit acid and the like, so that the irritation of the products is increased, the situation of dry desquamation of the skin application area of a subject is avoided, the skin repair and maintenance are not facilitated, and the applicable crowd range of the products is limited. In addition, cosmetic treatments for lightening pigments are generally based on chemical ecdysis, other treatment regimens including laser technology, however, these regimens may all lead to complications, including dermal melanin deposition and inflammation. In addition, the prior art does not pay attention to the effects of eliminating acnes and reducing pores while repairing acne pits.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide the guaiac composition capable of effectively fading red and black acne marks, smoothening acne pits, shrinking pores, avoiding the recurrence of the red and black acne marks, fading the acne marks and smoothening the acne pits gently and not irritating, and the application thereof.
To achieve the above object, in a first aspect of the present invention, there is provided a guaiac composition for reducing acne marks and smoothening out acne pits, comprising the following components in parts by weight:
0.2-10 parts of onion extract, 0.1-2 parts of plant ecdysteroid, 0.1-5 parts of guaiacum extract, 0.1-2 parts of VC derivative and 0.1-1 part of light black giant seaweed extract.
The guaiac composition provided by the invention is prepared by selecting and adding onion extract, plant ecdysteroid, guaiac extract, VC derivative and light black giant seaweed extract in proper mass parts, and 5 components can be mutually cooperated, so that the problems of different types of pigmentation, acne pit residue, enlarged pores and sensitive skin state after acne can be solved. Specifically, the components of the guaiac composition provided by the invention can be matched with each other, so that the guaiac composition can effectively inhibit inflammation, promote the growth and synthesis of intercellular matrixes, accelerate skin metabolism, effectively improve darkness, lighten red and black acne marks, smooth acne pits, reduce pores, relieve redness and stinging of skin caused by acne, strengthen skin tolerance, reduce the sensitive state of the skin, prevent acne and avoid the problem of recrudescence of the red and black acne marks after the acne.
The research of the invention discovers that onion extract contains abundant substances such as quercetin, volatile oil, flavonoid and the like, can promote the generation of MMP-1, down regulate inflammatory factors IL-6, integration factors beta and vascular endothelial growth factors VGEF, inhibit the excessive proliferation of fibroblasts, and has the effects of preventing scar hyperplasia, softening scar, resisting oxidation and relieving skin inflammation. The plant ecdysteroid is a purely natural organic compound extracted from plants, and can increase protein synthesis, strengthen functional systems damaged by pressure, and protect against damage caused by various environments and pressures. The guaiac extract contains rich lignin, quinone, saponin, sesquiterpene and triterpene components, has the effects of resisting inflammation, virus and bacteria, astringing and repairing, can inhibit excessive grease in sebaceous glands, prevent the excessive grease from developing into inflammatory acnes, and has certain healing promotion effect on acne marks and acne pits. The VC derivative has milder and stable effect and good permeability on the basis of the original effect of VC, and can exert good biological activity on skin. The extract of the light black giant seaweed contains active ingredients such as polysaccharides, terpenes, proteins, polyphenols, cyclic polysulfide and the like, and has biological activities such as antioxidation, anti-tumor, blood lipid and blood sugar reduction, immunity improvement and the like. The combination of the components can achieve the excellent effects of fading acne marks, smoothing acne pits and shrinking pores, and has the characteristics of relieving stinging, mildness and no irritation.
As a preferred embodiment of the guaiac composition of the present invention, the guaiac composition comprises the following components in parts by weight: 1-8 parts of onion extract, 0.3-1.5 parts of plant ecdysteroid, 1-3 parts of guaiacum extract, 0.3-1 part of VC derivative and 0.3-0.7 part of light black giant seaweed extract.
As a preferred embodiment of the guaiac composition of the present invention, the guaiac composition comprises the following components in parts by weight: 2-3 parts of onion extract, 0.5-0.8 part of plant ecdysteroid, 1.5-2 parts of guaiacum extract, 0.5-0.6 part of VC derivative and 0.5-0.6 part of light black giant seaweed extract.
According to the research of the invention, the components in the guaiac composition have mass parts which can influence the performance of the product, and when the mass parts of the components are further selected within the range, the obtained product has more excellent effects of fading red and black acne marks and smoothening acne pits, and can also remarkably shrink pores and relieve stinging, thereby being beneficial to acne mark removal, acne pit repair and skin maintenance and relief of sensitive skin people.
As a preferred embodiment of the guaiac composition of the present invention, the guaiac composition further comprises the following components in parts by mass: 0.05-1 part of 4-tertiary butyl cyclohexanol, 0.025-0.5 part of saffron extract and 0.025-0.5 part of green soy bean seed extract.
The research of the invention discovers that 4-tertiary butyl cyclohexyl alcohol is a TRPV1 antagonist, can have good relieving effect on stimulation response induced by TRPV1 activation, the saffron extract is rich in flavonoid compounds, and the grifolin extract is rich in grifolin, and has stronger anti-inflammatory effect; the three components are mixed with onion extract, plant ecdysteroid, guaiacum extract, VC derivative and light black giant seaweed extract for use, so that excellent interaction relationship can be achieved, a better stinging relieving effect of the guaiacum composition is further provided, the repairing capability of sensitive skin of acne patients is improved, and the effects of repairing acne pits, removing acne marks and tightening pores are enhanced.
As a preferred embodiment of the guaiac composition of the present invention, the guaiac composition further comprises the following components in parts by mass: 0.2-0.8 part of 4-tertiary butyl cyclohexanol, 0.1-0.4 part of saffron extract and 0.1-0.4 part of green soybean seed extract.
As a preferred embodiment of the guaiac composition of the present invention, the mass parts ratio of the 4-t-butylcyclohexanol, saffron extract and grifola fron seed extract is 4-t-butylcyclohexanol: saffron extract: green soy bean seed extract = 1: (0.4-0.6): (0.4-0.6).
The present inventors have found that when the parts of 4-t-butylcyclohexanol, saffron extract and green soybean seed extract are further selected within the above-mentioned ranges, and the mass ratio of 4-t-butylcyclohexanol, saffron extract and green soybean seed extract is further selected within the above-mentioned ranges, the resulting guaiacum composition is more excellent in comprehensive effect.
As a preferred embodiment of the guaiac composition of the present invention, the guaiac composition has a mass percentage of onion extract of 26 to 64%.
As a preferred embodiment of the guaiac composition of the present invention, the guaiac composition comprises 6 to 12% by mass of the extract of the light black giant seaweed.
Preferably, the guaiac composition comprises onion extract in an amount of 26 to 40% by mass.
Preferably, the guaiacum composition comprises 6 to 10 mass% of the extract of the light black giant seaweed.
The research of the invention finds that when the mass percentage of onion extract and light black giant seaweed extract in the guaiacum composition is further controlled within the above range, especially the further preferable range, the product has better capability of fading red and black acne marks and better repairing effect on acne pits.
As a preferred embodiment of the guaiac composition of the present invention, the onion extract is prepared by the following method: drying and pulverizing Bulbus Allii Cepae, sieving to obtain Bulbus Allii Cepae coarse powder, adding extraction solvent, performing ultrasonic extraction, vacuum filtering, filtering with microporous membrane, concentrating and drying to obtain Bulbus Allii Cepae extract; the extraction solvent is ethanol water solution with pH value of 5.5-7.5.
According to the invention, the effects of the obtained guaiac composition are different when onion extracts prepared by different extraction methods are added into the guaiac composition, and the comprehensive effect of the obtained guaiac composition is better when the onion extracts are selected to be prepared by the method.
Preferably, onions are screened before drying and crushing, and onions with good quality are selected.
Preferably, the crushing is to crush the dried onion to 100-200 meshes.
Preferably, the solid-to-liquid ratio at the time of ultrasonic extraction is 1: (10-20), the temperature is 40-50 ℃, the time is 1-2h, and the ultrasonic frequency is 40-60kHz.
Preferably, the drying in the concentrated drying of the extracting solution is low-temperature drying in a vacuum drying oven, and the drying temperature is 30-40 ℃.
Preferably, in the ethanol aqueous solution, the volume fraction of ethanol is 60-80%.
The onion extract prepared by the extraction method of the invention has the main active ingredients with the mass percentages as follows: 8-10% of polysaccharides, 80-90% of flavonoids, trace volatile oils and trace phenylpropanoids.
The research of the invention finds that when the parameters in the extraction process are further selected to be the values, the onion extract obtained by extraction is applied to the guaiacum composition, and the obtained guaiacum composition has more excellent comprehensive effect.
As a preferred embodiment of the guaiacum composition of the present invention, the method for preparing the extract of the light black giant seaweed comprises the steps of:
(1) Drying and pulverizing light black giant seaweed, sieving to obtain light black giant seaweed coarse powder, adding an extraction solvent, performing ultrasonic extraction, collecting an extracting solution and filter residues, concentrating and freeze-drying the extracting solution to obtain a freeze-dried product 1;
(2) Mixing the filter residue with distilled water, performing ultrasonic extraction, collecting filtrate, adding 3-5 times of absolute ethyl alcohol, standing at 0-5deg.C overnight, centrifuging to separate supernatant, concentrating, and lyophilizing to obtain lyophilized product 2;
(3) Combining the lyophilized product 1 and the lyophilized product 2 to obtain a light black giant seaweed extract;
in the step (1), the extraction solvent is ethanol water solution with the pH value of 5.5-7.5.
As a preferred embodiment of the guaiacum composition of the present invention, the volume fraction of ethanol in the extraction solvent is 50-70%.
According to the research, when the extraction method is adopted to extract the light black giant seaweed extract, the obtained light black giant seaweed extract can help to realize better effects of removing acne marks, smoothing acne pits and shrinking pores when being applied to a guaiac composition.
Preferably, the crushing is to crush the dried light black giant seaweed to 100-200 meshes.
Preferably, in the step (1), the solid-to-liquid ratio at the time of ultrasonic extraction is 1: (9-12), the temperature is 40-50 ℃, the time is 1-2h, and the ultrasonic frequency is 40-60kHz.
Preferably, in the step (2), the solid-to-liquid ratio at the time of ultrasonic extraction is 1: (35-45), the temperature is 50-70 ℃, the time is 0.5-1h, and the ultrasonic frequency is 40-60kHz.
Preferably, the lyophilization is low temperature drying in a vacuum freeze-drying oven at (-18) -10deg.C.
As a preferred embodiment of the guaiacum composition of the present invention, the plant ecdysteroid comprises at least one of 20-hydroxyecdysteroid, ecdysone, ajugasterone C, terra alba B, pinasterone A, arvenone A, praecoasterone D, cyasterone, and hydroxy cyasterone.
In one embodiment, the plant ecdysteroid is 20-hydroxyecdysteroid.
As a preferred embodiment of the guaiac composition of the present invention, the VC derivative includes at least one of tetraisopalmitate ascorbate, 3-O-ethyl ascorbate, ascorbyl glucoside, ascorbyl palmitate, magnesium ascorbyl phosphate.
In one embodiment, the VC derivative is 3-O-ethyl ascorbic acid.
In a second aspect of the present invention, there is provided a method of preparing the guaiac composition, the method comprising the steps of: the components are uniformly mixed to obtain the guaiac composition.
In a third aspect of the invention, the invention provides the use of the guaiac composition in the preparation of a cosmetic.
The guaiac composition provided by the invention can be used as an effective component to be added into different cosmetics, so that the problems of skin sensitivity caused by acne are solved, such as relieving stinging, removing acne marks, smoothing acne pits and refining pores.
In a fourth aspect of the invention, the invention provides a cosmetic comprising the guaiac composition of the invention.
As a preferred embodiment of the cosmetic according to the invention, the cosmetic comprises the following components in mass percent: 0.1-3% of guaiac composition, 4-40% of cosmetic matrix and the balance of water.
As a preferred embodiment of the cosmetic according to the present invention, the cosmetic base includes at least one of a thickener, a humectant, an emulsifier, a preservative, a perfume, and a pH adjuster.
As a preferred embodiment of the cosmetic according to the invention, the cosmetic comprises the following components in mass percent: 0.1-3% of guaiac composition, 0.05-0.5% of thickener, 3-20% of humectant, 0.5-10% of emulsifier, 0.2-5% of preservative, 0.01-0.2% of essence, 0.05-0.1% of pH regulator and the balance of water.
Illustratively, the thickener comprises at least one of xanthan gum, carbomer 940, AVC, polymeric cellulose; the humectant comprises at least one of glycerin, butanediol and low molecular sodium hyaluronate; the emulsifier comprises at least one of coco-caprylate/caprate, polydimethylsiloxane, hydrogenated palm kernel oil, cetostearyl alcohol, polyglycerol-6 distearate and polymethylsilsesquioxane; the preservative comprises at least one of 1, 3-propanediol, 1, 2-hexanediol and p-hydroxyacetophenone; the pH regulator comprises at least one of arginine and EDTA-2 Na.
As a preferred embodiment of the cosmetic according to the present invention, the cosmetic includes any one of a lotion, an emulsion, a cream, a mask, an essence, and a spray.
In a fifth aspect of the present invention, there is provided a method for preparing a cosmetic, the method comprising the steps of:
(1) Mixing humectant, thickener and part of pH regulator with water, stirring, heating to 80-90deg.C, homogenizing at 1000-1400rpm for 3-5min, and keeping the temperature after homogenizing to obtain prefabricated component A;
(2) Mixing the emulsifying agent, heating to 70-80deg.C, homogenizing at 1000-1400rpm for 3-5min, and maintaining the temperature after homogenizing to obtain prefabricated component B;
(3) Mixing the preservative, heating to 55-65 ℃ and melting to obtain a prefabricated component C;
(4) Heating the prefabricated component A to 75-85 ℃, adding the prefabricated component B at a rotating speed of 200-500rpm, stirring and mixing, cooling to 55-65 ℃, adding the prefabricated component C at a rotating speed of 200-500rpm, stirring and mixing, cooling to below 45 ℃, adding the guaiac composition, continuously stirring for 5-10min, finally adding the rest pH regulator to adjust the pH to 5.0-6.5, stopping stirring, and discharging to obtain the cosmetic.
Compared with the prior art, the invention has the beneficial effects that:
the invention provides a guaiac composition for removing acne marks and smoothing acne pits, wherein 5 components in the guaiac composition can be matched with each other, and the acne mark removing effect in all stages can be achieved within the given range; specifically, acne marks and acne pits can be removed from five dimensions, and the good state of skin can be recovered; the first dimension is that the composition can effectively inhibit skin inflammation and eliminate red acne marks; the second dimension is that tyrosinase can be inhibited, melanin synthesis can be reduced, and black acne marks can be reduced; the third dimension is that the skin matrix regeneration can be promoted, scars can be prevented and reduced, acne pits can be smoothed, and skin textures can be smoothed; the fourth dimension is that the skin barrier can be repaired, the skin sensibility is reduced, and the tough state of the skin is restored; the fifth dimension is that pores of the skin can be reduced, and the skin is fine and smooth. Namely, the guaiac composition plays a good role in preventing and improving the whole process of acne mark formation, has pertinence and comprehensiveness, and can be widely applied to products for removing acne marks, smoothening acne pits, improving pigment deposition after inflammation, refining pores and relieving and stabilizing. Further, after 4-tert-butylcyclohexanol, saffron extract and green soybean seed extract are introduced into the guaiacum composition, a more excellent post-inflammatory relief effect can be obtained; the guaiac composition provided by the invention is mild and non-irritating in whole, has a wide application range, and can prevent acne recurrence; the guaiac composition can also achieve the effect of improving skin qualification and promote skin texture when being applied to the preparation of cosmetics. In addition, the guaiac composition provided by the invention has natural component sources, and the preparation method is simple and is suitable for actual production.
Drawings
FIG. 1 is a graph showing the results of scar repair in mice in effect example 3;
FIG. 2 is a graph showing the result of the movement distance of the zebra fish embryo in effect example 4;
FIG. 3 is a graph showing the results of human arm patch in effect example 5;
FIG. 4 is a graph showing the results of improving red and black blemish marks on the face of a human body in effect example 6;
FIG. 5 is a graph showing the results of repairing the pits on the face of the human body in effect example 7;
fig. 6 is a graph showing the result of refining pores in the human body surface in effect example 7.
Detailed Description
For a better description of the objects, technical solutions and advantages of the present invention, the present invention will be further described with reference to the following specific examples.
The reagents, methods and apparatus employed in the present invention, unless otherwise specified, are all those conventional in the art; and the raw materials used in parallel experiments are the same batch of raw materials without special description.
Onion extract 1: the preparation method comprises the following steps: crushing the dried wampee onion to 100 meshes, and then adding an ethanol aqueous solution with the pH value of 6 and the volume fraction of 70%, wherein the solid-to-liquid ratio is 1:15, then ultrasonic treating at 45+ -3deg.C and 45kHz frequency for 2 hr, filtering after ultrasonic treatment, collecting extractive solution, concentrating, and vacuum drying the concentrate at 35deg.C to obtain Bulbus Allii Cepae extract 1;
Onion extract 2: the preparation method comprises the following steps: crushing dried wampee onion to 100 meshes, and then adding water, wherein the solid-liquid ratio is 1:10, extracting under reflux for 1.5h, filtering after extraction, concentrating the extractive solution, and vacuum drying the concentrate at 35deg.C to obtain onion extract 2;
extract 1 of light black giant seaweed: the preparation method comprises the following steps:
(1) Crushing the dried light black giant seaweed to 100 meshes, and then adding an ethanol aqueous solution with the pH value of 6 and the volume fraction of 55%, wherein the solid-to-liquid ratio is 1:10, then carrying out ultrasonic treatment at 45+/-3 ℃ for 1h at the frequency of 45kHz, filtering after ultrasonic treatment, collecting an extracting solution and filter residues, concentrating the extracting solution, and freeze-drying at-18 ℃ to obtain a freeze-dried product 1;
(2) Mixing the filter residue with distilled water at a solid-to-liquid ratio of 1:40, performing ultrasonic treatment at 60+ -3deg.C and 45kHz frequency for 45min, filtering after ultrasonic treatment, collecting filtrate, adding 4 times volume of absolute ethanol, standing at 4deg.C overnight, centrifuging to separate supernatant, concentrating the supernatant, and lyophilizing at-18deg.C to obtain lyophilized product 2;
(3) Combining the lyophilized product 1 and the lyophilized product 2 to obtain a light black giant seaweed extract 1;
extract 2 of light black giant seaweed: the self-made preparation method is different from the light black giant seaweed extract 1 in the step (1), and the step (1) in the preparation of the light black giant seaweed extract 2 is as follows: crushing the dried light black giant seaweed to 150 meshes, and then adding an ethanol aqueous solution with the pH value of 6 and the volume fraction of 30%, wherein the solid-to-liquid ratio is 1:10, then carrying out ultrasonic treatment at 45+/-3 ℃ for 2 hours at a frequency of 60kHz, filtering after ultrasonic treatment, collecting an extracting solution for concentration, and then collecting a concentrate for vacuum freeze drying at-10 ℃ to obtain the light black giant seaweed extract 2;
Extract 3 of light black giant seaweed: the self-made preparation method is different from the light black giant seaweed extract 1 in the step (1), and the step (1) in the preparation of the light black giant seaweed extract 3 is as follows: crushing the dried light black giant seaweed to 150 meshes, and then adding water, wherein the solid-to-liquid ratio is 1:10, reflux-extracting for 2h, filtering after extraction, collecting the extract, concentrating, and vacuum freeze-drying the concentrate at 10deg.C to obtain light black giant seaweed extract 3;
guaiacum (GUAIACUM OFFICINALE) wood extract, saffron (CROCUS SATIVUS) extract, green soy (TEPHROSIA PURPUREA) seed extract are all commercially available.
Examples 1 to 8 and comparative examples 1 to 5
Examples 1 to 8 and comparative examples 1 to 5 of the present invention provide a guaiac composition whose components (parts by mass) are shown in table 1;
TABLE 1
The guaiac composition provided in example 1 was prepared by: the components are uniformly mixed to obtain the guaiac composition.
The preparation methods of the guaiac compositions provided in examples 2 to 8 and comparative examples 1 to 5 were consistent with example 1.
Example 9
The present example provides a guaiac composition that differs from example 6 only in that onion extract 2 is substituted for onion extract 1.
Example 10
The present example provides a guaiacum composition which differs from example 6 only in that the light black giant seaweed extract 2 is used instead of the light black giant seaweed extract 1.
Example 11
The present example provides a guaiacum composition which differs from example 6 only in that the light black giant seaweed extract 3 is used instead of the light black giant seaweed extract 1.
Comparative example 6
The comparative example of the present invention provides a guaiacum composition which differs from example 6 only in that garlic extract is substituted for onion extract 1.
Comparative example 7
The comparative example of the present invention provides a guaiacum composition which differs from example 6 only in that the guaiacum extract is replaced by centella asiatica extract.
Comparative example 8
The comparative example of the present invention provides a guaiacum composition which differs from example 6 only in that the extract of Alternaria alternata is replaced with the extract of Alternaria alternata.
Comparative example 9
The comparative example of the present invention provides a guaiac composition which differs from example 6 only in that alpha-tocopherol is used instead of 3-O-ethyl ascorbic acid.
Application examples 1 to 12, comparative application examples 1 to 11 and blank application examples
The present invention application examples 1 to 12, comparative application examples 1 to 11 and blank application examples provide emulsions whose components (mass percentages) are shown in table 2; the guaiac compositions in application examples 1 to 11 were the guaiac compositions prepared in examples 1 to 11, respectively, and the guaiac compositions in comparative application examples 1 to 9 were the guaiac compositions prepared in comparative examples 1 to 9, respectively; the guaiac composition used in application example 6 is the guaiac composition prepared in example 6, and so on; the guaiac composition used in application example 12 was the guaiac composition prepared in example 6;
TABLE 2
The preparation method of the emulsion provided in application example 1 comprises the following steps:
(1) Mixing the component A with water, stirring, heating to 80 ℃, homogenizing for 5min at 1200rpm, and preserving heat for later use after homogenizing to obtain a prefabricated component A;
(2) Mixing the component B, heating to 80 ℃, homogenizing for 5min at a rotation speed of 1200rpm, and preserving heat for later use after homogenizing to obtain a prefabricated component B;
(3) Mixing the components C, heating to 60 ℃ and melting to obtain a prefabricated component C;
(4) Heating the prefabricated component A to 80 ℃, adding the prefabricated component B at the rotation speed of 300rpm, stirring and mixing, cooling to 60 ℃, adding the prefabricated component C at the rotation speed of 300rpm, stirring and mixing, cooling to below 45 ℃, adding the guaiac composition, continuously stirring for 5min, finally adding arginine to adjust the pH to 5.0-6.5, stopping stirring, and discharging to obtain the emulsion.
The preparation methods of the emulsions provided in application examples 2 to 12, comparative application examples 1 to 11 and blank application example were kept consistent with application example 1, and the emulsions were not added without the relevant components.
Effect example 1
The effect example of the present invention verifies the inhibitory effect of the guaiac compositions prepared in examples 1 to 11 and comparative examples 1 to 9 on tyrosinase activity, which is a key enzyme in skin melanin biosynthesis, acting on dopa to form dopaquinone, which spontaneously undergoes a series of reactions to finally form melanin; tyrosinase catalyzes the conversion of dopa to dopaquinone in phosphate buffer solution at pH 6.8-7.4, and absorbance at 475nm is measured by spectrophotometer; the raw material with tyrosinase activity inhibition effect can reduce the conversion of dopa into dopaquinone, thereby reducing absorbance value, and can evaluate the inhibition effect of the raw material on tyrosinase activity according to the change of absorbance value.
The testing process specifically comprises the following steps:
diluting 25KU tyrosinase with PBS buffer solution to prepare 200U tyrosinase solution;
10% sample solutions were prepared by diluting examples 1-11 and comparative examples 1-9 with PBS buffer;
preparing a sample tube and a blank control tube according to the following A, B, C, D tube solution, adding 0.5mL of 5% L-dopa solution into each tube after preparing, reacting for 30min at a constant temperature of 37 ℃, measuring absorbance value of the mixed solution at 475nm, and repeating each sample for 3 times; the test results are shown in Table 3:
Wherein, A, B, C, D test tube solution was prepared as follows:
a pipe A: 3mL PBS buffer+0.5 mL tyrosinase;
and B, pipe B: 3.5mL of PBS buffer;
c pipe: 1mL of sample solution+2 mL of LPBS buffer+0.5 mL of tyrosinase;
d pipe: 1mL of sample solution+2.5 mL of PBS buffer;
zeroing: a PBS solution;
calculating tyrosinase inhibition rate: inhibition ratio = 1- (C-D)/(a-B) ×100%;
TABLE 3 Table 3
As can be seen from Table 3, when the technical scheme of the invention is adopted, the inhibition rate of the obtained guaiac composition to tyrosinase is higher and is more than 72.28 percent; the inhibition rate of tyrosinase activity by the obtained guaiacum composition is remarkably reduced when any one of onion extract, plant ecdysteroid, guaiacum extract, VC derivative or light black giant seaweed extract is absent, and the obtained effect is far inferior to that obtained by adopting the technical scheme of the present invention when other similar components are substituted.
Effect example 2
This effect example explores the anti-inflammatory effects of the guaiac compositions prepared in examples 1-11 and comparative examples 1-9, which were shown to activate Toll-like receptors (TLR-2 and TLR-4) on keratinocytes, resulting in activation of MAPK and NF- κB pathways. Keratinocytes then produce inflammatory factors, such as TNF- α, which induce inflammatory production, wherein the primary ligand for TLR-2 is a peptidoglycan of a gram positive bacterium. The effect example evaluates the anti-inflammatory effect of samples by detecting secreted TNF- α in the cell supernatant.
The cell line used was HaCaT cells, passage times: 14, test conditions are: the temperature of the incubator is 37+/-1 ℃, the humidity is 90+/-5% and the carbon dioxide is 5+/-1%. The experiment was set as negative control (NT): culture medium, model set (M): culture +50. Mu.g/mL peptidoglycan, test sample set (TA): sample solution+culture solution+50. Mu.g/mL peptidoglycan, positive control group (PC): 50. Mu.g/mL dexamethasone solution + broth + 50. Mu.g/mL peptidoglycan.
Preparing a test sample solution: taking 0.12g of the samples of each example and comparative example, adding 0.88mL of serum-free MEM to prepare a sample mother liquor with the concentration of 12%, and diluting the mother liquor into a 0.15% sample solution;
dexamethasone solution preparation: 0.025g dexamethasone is weighed, 1mL of methanol is added to prepare 25mg/mL stock solution, and then MEM is used for dilution to obtain working solution;
preparing a culture solution: MEM medium (FBS, gibco, lot: 2500251P) containing 10% fetal bovine serum;
preparing a negative control group culture solution: 5mL of 1% penicillin and 1% streptomycin are added into 500mL of MEM culture medium to prepare a culture medium storage solution, and the culture medium storage solution is mixed for later use;
MMT solution was used for conventional cell culture: MTT was prepared as a 5mg/mL solution of MTT from Sigma using PBS, sterilized by filtration using a 0.22 μm syringe filter, and stored at-20 ℃;
Peptidoglycan (PGN-SA) was purchased from InvivoGen; TNF-alpha kit was purchased from Shenzhen Xinbo.
The results obtained are shown in Table 4;
TABLE 4 Table 4
Group of TNF-alpha content (pg/mL) Group of TNF-alpha content (pg/mL)
NT 79.36±4.48* Comparative example 1 96.92±1.88
M 92.33±2.25 Comparative example 2 89.36±4.05
PC 77.27±2.96* Comparative example 3 95.35±6.88
Example 1 65.63±3.15* Comparative example 4 85.36±5.07
Example 2 71.36±5.07* Comparative example 5 90.36±4.17
Example 3 75.29±1.88* Comparative example 6 86.96±2.17
Example 4 77.35±6.88* Comparative example 7 85.44±5.00
Example 5 78.02±1.88* Comparative example 8 85.63±3.27
Example 6 35.27±4.94* Comparative example 9 88.11±1.57
Example 7 51.28±2.30*
Example 8 53.40±3.00*
Example 9 69.32±2.75*
Example 10 67.02±1.73*
Example 11 62.08±5.23*
Remarks: * The differences were statistically significant (p < 0.05) compared to the model group
As can be seen from table 4, when the technical scheme of the invention is adopted, the obtained guaiac composition can effectively inhibit the inflammatory reaction of keratinocytes, reduce the TNF-alpha content, and has remarkable effect compared with the model group; the inhibition of inflammatory factors by the resulting guaiacum composition is significantly reduced when either one of onion extract, plant ecdysteroid, guaiacum extract, VC derivative or light black giant seaweed extract is absent, and the effect obtained when other similar components are substituted is far from that obtained by the technical scheme of the present invention.
Effect example 3
The effect examples of the invention verify the improvement effect of the emulsion prepared by application examples 1-12, comparative application examples 1-11 and blank application examples on the rat scar model; the method specifically comprises the following steps:
200 SPF-grade SD rats, male, were selected and offered by Guangdong Vetolihua laboratory animal technologies Inc. After purchasing, 8 animals are fed in each cage of the barrier environment animal house, and the animals are used after quarantine is qualified.
After the rats were anesthetized and shaved on the back, after the rats entered deep anesthesia, 2 circular wounds of 7mm were created in the shaved area on the back of the rats using a skin punch, the thickness of the wound being the whole layer of skin. 1 course of treatment per week, each course of treatment was applied for 5 days, and the positive control was human epidermal growth factor gel. Photographs were taken with steel ruler comparisons on the day of molding, day 7 and day 14, respectively. Animals were euthanized on day 14, skin wound was harvested, fixed with fixative, transected and tableted, and HE stained for qualitative analysis of wound inflammation and neonatal tissue status. The healing of days 12, 13 and 14 was measured using Image-Pro Plus 6.0, and the rate of healing was 100%, which was regarded as healing, and the number of mice healed on days 12, 13 and 14 was calculated as the ratio.
Wherein the healing rate (%) = (AO-At)/ao×100%
AO: area of initial wound surface;
At: residual wound area at each time point.
The results obtained are shown in Table 6;
meanwhile, in the pathological scoring of skin injury on the 7 th day, the degree of epithelial necrosis, leukocyte infiltration, neovascularization and skin edema of mice in different groups are experimentally evaluated, and scoring is carried out according to the pathological scoring in the table 5, and the average value is obtained; the results obtained are shown in Table 6;
TABLE 5
TABLE 6
As can be seen from table 6, the emulsion obtained by the technical scheme of the invention has excellent wound healing rate, wherein the 14d healing rate can reach 87.50%; and from the skin injury pathological score of the 7d, the technical scheme of the invention can obviously improve the skin state, lighten the conditions of epithelial necrosis, erosion and leukocyte infiltration, namely obviously improve the inflammatory condition of the skin, promote angiogenesis, effectively improve the skin edema phenomenon and promote skin healing regeneration. When the guaiacum composition obtained in comparative application examples 1 to 5, either lacks any one of onion extract, plant ecdysteroid, guaiacum extract, VC derivative or light black giant seaweed extract, the rate of wound healing by the obtained emulsion is significantly reduced when the guaiacum composition is added to the emulsion; and when the efficacy components used in the added guaiac composition of comparative application examples 6 to 9 are not the components in the present invention but other similar components, the effect obtained by adding them as a whole into the emulsion is far less than that obtained by adopting the technical scheme of the present invention; when comparative application examples 10 to 11 used other effective components having a certain wound repair ability in place of the guaiac composition of the present invention in equal amounts, the effect of the obtained emulsion was also significantly reduced.
In addition, as shown in fig. 1, the result of the scar repairing effect of the emulsion in application example 6 on mice is shown in fig. 1, and it is obvious from fig. 1 that the emulsion provided in application example 6 can obviously promote skin regeneration, improve healing repairing force, improve inflammation, promote angiogenesis and improve skin edema.
Effect example 4
The effect example of the invention verifies the stimulation release rate of the emulsion prepared by application example 1, application examples 6-12, comparative application examples 1-11 and blank application examples on zebra fish embryo; the capsaicin pathway on human skin can be activated by capsaicin, acidity and temperatures above 42 ℃. Zebra fish also have capsaicin pathways and can be activated at high temperatures, peaking at 37 ℃ or above, exhibiting a significant increase in swimming speed. Therefore, the motion distance reduction rate is calculated by applying the motion distance change of the zebra fish and the zebra fish embryo of the model control group activated at high temperature to evaluate the soothing effect of the raw material or the product, and the larger the motion distance reduction rate is, the better the soothing effect is.
The wild type AB strain zebra fish (Danio rerio) test with reliable source (such as China national zebra fish resource center) is applied. The experimental steps are as follows:
healthy 5-day post-fertilization large zebra fish embryos were selected in 96-well plates and exposed to each experimental group, with model controls: randomly selecting 16 fish embryos into 96-well plates, wherein each well contains one fish embryo and 0.2mL of fish embryo culture solution, and the positive control group: 16 fish embryos are randomly selected into 96-well plates, each well containing one fish embryo and 0.2mL of 0.05 g/L4-t-butylcyclohexanol solution, sample group: 16 fish embryos are randomly selected into 96-well plates, each well containing one fish embryo and 0.2ml of 20g/L sample solution (samples were directly lysed with fish embryo culture solution to prepare test sample solutions). After 2h exposure at 28℃the swimming track of each zebra fish in the dark was recorded as the movement distance and statistically analysed using Ethovision XT IR tracking software in a Daniovision zebra fish movement recorder which had been preheated to 38 ℃.
Data and result calculation: measuring and reading the pixel intensity of each hole as the movement distance of each fish embryo;
calculating a motion distance reduction rate: reduction rate= (M-S)/mx100%;
s: average value of the movement distance of the fish embryo of the test object treatment group;
m: average value of embryo movement distance of model group fish.
The results obtained are shown in Table 7;
TABLE 7
/>
Remarks: * The differences were statistically significant (p < 0.05) compared to the model group
As can be seen from Table 7, when the technical scheme of the invention is adopted, the obtained emulsion can remarkably shorten the movement distance of the zebra fish embryo, and the reduction rate is more than 27%. When the guaiacum composition obtained in comparative application examples 1 to 5, whether it lacks any one of onion extract, plant ecdysteroid, guaiacum extract, VC derivative or light black giant seaweed extract, was added to the emulsion, the effect of the obtained emulsion on relieving stinging was significantly reduced; and when the efficacy components used in the added guaiac composition of comparative application examples 6 to 9 are not the components in the present invention but other similar components, the effect obtained by adding them as a whole into the emulsion is far less than that obtained by adopting the technical scheme of the present invention; when comparative application examples 10 to 11 used other similar functional components in place of the guaiac composition of the present invention in equal amounts, the effect of the resulting emulsion was also significantly reduced.
In addition, the graph of the result of the emulsion in application example 6 on the movement distance of the zebra fish embryo at high temperature is shown in fig. 2, and it can be obviously seen from fig. 2 that the emulsion provided in application example 6 can remarkably reduce the movement distance of the zebra fish embryo, so as to achieve the effect of relieving stinging.
Effect example 5
The effect examples of the present invention verify the safety of application example 1, application examples 6 to 12, comparative application examples 1 to 11 and blank application examples on human skin. According to the human skin patch test (cosmetic safety technical Specification) (2015), 33 volunteers 18-60 years old are recruited in the test, and the test environment is the temperature (21+/-1) DEG C and the humidity (50+/-10)%. The volunteer cleans the forearms with clear water, after 5-10 minutes, after the moisture of the forearms volatilizes, the tester applies 0.020-0.025 mL of each group of sample emulsion to each cell of the 10-hole spot tester, selects the inner sides of the two forearms of the volunteer, avoids the skin at the joint movement positions of the front and rear hands, each arm is respectively attached with the spot tester with the sample, and makes corresponding marks, the patch time lasts for 24 hours, the spot tester is removed to wipe residual samples, skin reactions of 0.5 hours, 24 hours and 48 hours are observed, and the results are recorded according to the skin reaction grading standard in cosmetic safety technical Specification (2015). Skin reactions were classified into 4 scoring scales as in table 8, with higher severity of skin irritation reactions as the score was higher.
The test results are shown in Table 9, and it is clear from the test results that the invention provides 0 cases of withdrawal and 0 cases of allergy to rubberized fabric in the technical scheme. When the guaiacum composition obtained in comparative application examples 1 to 5, either lacks onion extract, plant ecdysteroid, guaiacum extract, VC derivative or light black giant seaweed extract, was added to the emulsion, the emulsion obtained had a certain irritation; and when the efficacy ingredient used in the added guaiac composition of comparative application examples 6 to 11 is not the component of the present invention but other similar components, the effect obtained by adding it as a whole to the emulsion is far less than that obtained by adopting the technical scheme of the present invention, wherein application examples 7 to 8 show a 1-stage reaction within 0.5h, application examples 9 to 11 show a 1-stage reaction in an amount of 3 or more within 0.5h, whereas comparative application examples 1 to 11 show a 1-stage reaction in an amount of 5 or more within 0.5h, respectively. In contrast, application examples 6 to 8 and application example 12 were milder and safer, with application example 6 and application example 12 being non-irritating; wherein the picture during the actual test is shown in fig. 3.
TABLE 8
TABLE 9
/>
/>
/>
Effect example 6
The effect examples of the invention verify the application effects of application examples 6-11 and blank application examples for improving acne marks on human bodies, wherein red acne marks and black acne marks are respectively generated in the early stage and the later stage of acne mark formation, the red acne marks are vascular dilatation and inflammatory reaction caused by long acne marks, and if the red acne marks are not maintained or removed in time, the skin is gradually deepened into black acne marks, and the black acne marks are intractable and easy to relapse. The red and black acne marks can be identified according to naked eye identification or non-invasive instrument detection. The present invention was therefore targeted towards the colour exhibited by the acne marks at different times.
The method specifically comprises the following steps:
according to the test of cosmetic safety technical Specification (2015), 80 Asian adult testers 18-60 years old, 10 people in each group, with more obvious acne marks, are selected, under normal conditions, the volunteers continuously use the product for 28 days on the whole face, and the acne mark removing efficacy of different groups of products is evaluated by taking the product containing 3% of nicotinamide (comparative application example 10, which has a great deal of research shows that the nicotinamide lightens pigment, accelerates the exfoliating of horny substances and promotes metabolism to play a role) as a positive control. The method comprises the following specific steps:
the volunteers use the lotion for 1 time in the morning and evening after moisturizing the face, and the lotion is smeared on the acne marks and the acne pits, the massage and the absorption are carried out, and the whole face is used for 1 time in the morning and evening, and the group of 10 people is accessed again in days 3, 7, 14, 21 and 28. The volunteers were not smeared with any product after visiting the test area on the same day and washing the face, and were sitting still for 20min in an air-conditioning room with a temperature of 21+ -1deg.C and a humidity of 50+ -10%. And quantifying and photographing different types of acne marks by adopting an instrument, wherein the values of a are measured by VISIA7, the values of heme content EI and melanin content MI are measured by MX18, and the acne mark area is measured by VISIA7 and IPP. The change in a and EI values may represent the improvement in red blemishes, with smaller data representing more pronounced red blemishes fading; the change in MI value may be indicative of the degree of improvement in black blemish, with smaller values indicating more pronounced black blemish fade. The improvement of the acne marks is represented by the improvement rate of each numerical value in the test, and the calculation mode is as follows:
Mean improvement rate with respect to blank value= (X Before-use mean value -X Mean value after use )/X Before-use mean value ×100%;
The results obtained are shown in Table 10;
table 10
Remarks: * The difference was statistically significant (p < 0.05) compared to the blank value
As can be seen from table 10, the emulsion prepared by the invention can effectively inhibit inflammatory erythema and pigmentation, reduce the area of red and black acne marks, inhibit the conversion of red acne marks into black acne marks and solve the recurrence of acne marks; the effect is obviously better than that of the emulsion added with the nicotinamide, and the acne marks are blackened when the emulsion added with the nicotinamide is not subjected to sun-screening treatment in the use process, the blackened phenomenon of the emulsion does not occur, the emulsion provided by the invention not only stays on the basis of fading the acne marks, but also can obviously reduce the average area of facial color spots, and the effects of homogenizing the facial complexion and improving the facial texture are achieved.
In addition, as shown in fig. 4, the result of the improvement of the emulsion in application example 6 on the red and black acne marks on the face of the human body is shown in fig. 4, and it is obvious from fig. 4 that the emulsion provided in application example 6 can obviously lighten the red and black acne marks and reduce the average area of the facial color spots.
Effect example 7
The effects of the invention prove the application effects of application examples 6-11 and blank application examples on the human body, namely, the effects of smoothing acne pits and refining pores, wherein the acne pits are serious in acne marks, and the skin is usually concave or collapses due to damage to dermis caused by external extrusion, so that the acne marks are easy to be in a permanent state. In addition, loss of collagen and imbalance in oil secretion due to reduced skin elasticity cause problems of enlarged pores after acne, affecting facial gloss and flatness. The experiment uses palmitoyl pentapeptide-4 (comparative application example 11) as a comparison, and the prior study shows that the palmitoyl pentapeptide-4 can obviously promote the generation of dermal matrix protein and help rebuild skin; promoting keratinocyte differentiation and maturation, promoting skin epithelia formation, increasing horny layer thickness and strengthening barrier layer of healthy skin, and has effect in eliminating acne pits.
The method specifically comprises the following steps:
80 subjects with acne pits on the face of 18-60 years old are selected according to the test of cosmetic safety technical Specification (2015), randomly divided into 8 groups, 10 persons in each group use the same product on the random whole face, and palmitoyl pentapeptide-4 (comparative application example 11) is used as a sample of an acne pit control group for 28 days, and the return visit is carried out on days 7, 14 and 28. 10 people, group 1. The volunteers visit the test area on the same day, clean the face without smearing any product, shoot the face image situation (VISIA 7& Primos CR) after sitting still for 20min in an air conditioning room with the temperature of 21+/-1 ℃ and the humidity of 50+/-10%, analyze the red area of the skin, the acne pit volume, the wrinkle depth, the wrinkle volume and the pore number, and the test shows the improvement situation of the acne pits and the pores by the improvement rate of each value, and the calculation mode is as follows:
mean improvement rate with respect to blank value= (X Before-use mean value -X Mean value after use )/X Before-use mean value ×100%;
The results obtained from the test are shown in Table 11;
TABLE 11
Remarks: * The difference was statistically significant (p < 0.05) compared to the blank value
As can be seen from table 11, the technical scheme of the invention can obviously reduce skin redness, slow down subcutaneous inflammation, reduce the volume of acne pits, fill skin, fine pores and smooth skin; when the guaiac composition is not added in the blank application example, the guaiac composition cannot play roles of removing acne pits, reducing skin inflammation and refining pores, and the number of the acne pits and pores instead shows a more serious trend along with the time; meanwhile, compared with comparative application example 11, the technical scheme provided by the invention also shows obvious advantages.
Further, the results of the lotion of application example 6 on repairing and refining the pits and pores of the human face are shown in fig. 5 and 6. The emulsion provided in application example 6 in the experimental result not only can obviously remove acne marks and fill the skin to achieve the effect of preventing acne pits (shown in fig. 5A), but also has remarkable effect of repairing the existing facial acne pits (shown in fig. 5B). Furthermore, it can be seen from fig. 6 that the number of detectable pores is significantly reduced. Therefore, the lotion provided in application example 6 can obviously repair acne pits, reduce skin pits and textures after acne, reduce the number of detectable pores, refine pores and smooth skin.
Finally, it should be noted that the above-mentioned embodiments illustrate rather than limit the scope of the invention, and that those skilled in the art will understand that changes can be made to the technical solutions of the invention or equivalents thereof without departing from the spirit and scope of the technical solutions of the invention.

Claims (17)

1. A guaiac composition for reducing acne marks and soothing acne pits, characterized in that the guaiac composition comprises the following components in parts by weight:
0.2-10 parts of onion extract, 0.1-2 parts of plant ecdysteroid, 0.1-5 parts of guaiacum extract, 0.1-2 parts of VC derivative and 0.1-1 part of light black giant seaweed extract.
2. The guaiac composition of claim 1, wherein said guaiac composition comprises the following components in parts by weight:
1-8 parts of onion extract, 0.3-1.5 parts of plant ecdysteroid, 1-3 parts of guaiacum extract, 0.3-1 part of VC derivative and 0.3-0.7 part of light black giant seaweed extract.
3. The guaiac composition of claim 2, wherein said guaiac composition comprises the following components in parts by weight:
2-3 parts of onion extract, 0.5-0.8 part of plant ecdysteroid, 1.5-2 parts of guaiacum extract, 0.5-0.6 part of VC derivative and 0.5-0.6 part of light black giant seaweed extract.
4. The guaiac composition of claim 1, further comprising the following components in parts by mass: 0.05-1 part of 4-tertiary butyl cyclohexanol, 0.025-0.5 part of saffron extract and 0.025-0.5 part of green soy bean seed extract.
5. The guaiac composition of claim 4, further comprising the following components in parts by mass: 0.2-0.8 part of 4-tertiary butyl cyclohexanol, 0.1-0.4 part of saffron extract and 0.1-0.4 part of green soybean seed extract.
6. The guaiac composition of claim 5, wherein the mass parts ratio of 4-t-butylcyclohexanol, saffron extract and green bean seed extract is 4-t-butylcyclohexanol: saffron extract: green soy bean seed extract = 1: (0.4-0.6): (0.4-0.6).
7. The guaiac composition of claim 1, wherein the mass percent of onion extract in said guaiac composition is 26-64%.
8. The guaiac composition of claim 1, wherein the guaiac composition comprises 6 to 12% by mass of the extract of the light black giant seaweed.
9. The guaiac composition of claim 1 wherein said onion extract is prepared by a process comprising: drying and pulverizing Bulbus Allii Cepae, sieving to obtain Bulbus Allii Cepae coarse powder, adding extraction solvent, performing ultrasonic extraction, vacuum filtering, filtering with microporous membrane, concentrating and drying to obtain Bulbus Allii Cepae extract;
the extraction solvent is ethanol water solution with pH value of 5.5-7.5.
10. The guaiacum composition of claim 1 wherein said extract of light black giant seaweed is prepared by a process comprising:
(1) Drying and pulverizing light black giant seaweed, sieving to obtain light black giant seaweed coarse powder, adding an extraction solvent, performing ultrasonic extraction, collecting an extracting solution and filter residues, concentrating and freeze-drying the extracting solution to obtain a freeze-dried product 1;
(2) Mixing the filter residue with distilled water, performing ultrasonic extraction, collecting filtrate, adding 3-5 times of anhydrous ethanol, standing at 0-5deg.C overnight, centrifuging to separate supernatant, concentrating, and lyophilizing to obtain lyophilized product 2;
(3) Combining the lyophilized product 1 and the lyophilized product 2 to obtain a light black giant seaweed extract;
in the step (1), the extraction solvent is ethanol water solution with the pH value of 5.5-7.5.
11. The guaiacum composition of claim 10, wherein the volume fraction of ethanol in the extraction solvent is 50-70%.
12. The guaiac composition of claim 1 wherein said phytoecdysterol comprises 20-hydroxyecdysterol, ecdysone, ajugasterone C, aquaporin B, pinacoloneA. At least one of Arhat pine sterone A, praecox sterone D, cup amarantrone and hydroxy cup amarantrone
13. The guaiac composition of claim 1, wherein said VC derivative comprises at least one of tetraisopalmitate ascorbate, 3-O-ethyl ascorbate, ascorbyl glucoside, ascorbyl palmitate, magnesium ascorbyl phosphate.
14. Use of the guaiac composition according to any one of claims 1 to 13 for the preparation of cosmetics.
15. A cosmetic product, characterized in that it comprises the guaiac composition according to any one of claims 1 to 13.
16. The cosmetic according to claim 15, characterized in that it comprises the following components in percentage by mass: 0.1-3% of guaiac composition, 4-40% of cosmetic matrix and the balance of water.
17. The cosmetic product of claim 15, wherein the cosmetic base comprises at least one of a thickener, a humectant, an emulsifier, a preservative, a fragrance, and a pH adjuster.
CN202311720109.8A 2023-12-13 2023-12-13 Guaiac composition for removing acne marks and smoothing acne pits and application thereof Active CN117679350B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311720109.8A CN117679350B (en) 2023-12-13 2023-12-13 Guaiac composition for removing acne marks and smoothing acne pits and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311720109.8A CN117679350B (en) 2023-12-13 2023-12-13 Guaiac composition for removing acne marks and smoothing acne pits and application thereof

Publications (2)

Publication Number Publication Date
CN117679350A true CN117679350A (en) 2024-03-12
CN117679350B CN117679350B (en) 2024-06-07

Family

ID=90126131

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311720109.8A Active CN117679350B (en) 2023-12-13 2023-12-13 Guaiac composition for removing acne marks and smoothing acne pits and application thereof

Country Status (1)

Country Link
CN (1) CN117679350B (en)

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007075425A (en) * 2005-09-15 2007-03-29 Mochida Pharmaceut Co Ltd Wound covering material including alginic acid
US20070231417A1 (en) * 2006-03-09 2007-10-04 Gundula Geske Use of guaiac wood for treating inflammation of the skin
US20080153776A1 (en) * 2006-12-21 2008-06-26 Erning Xia Method of Treating Inflammation of the Eye
KR20090060981A (en) * 2009-05-22 2009-06-15 김석 Tape of protecting ultraviolet rays
JP2015030713A (en) * 2013-08-06 2015-02-16 花精舎株式会社 Skin cosmetic comprising extract of male flower of reynoutria sachalinense
CN108066187A (en) * 2018-01-12 2018-05-25 广州赛莱拉干细胞科技股份有限公司 A kind of makeup remover and preparation method thereof
CN109862904A (en) * 2016-10-21 2019-06-07 阿尔吉法玛公司 Bacitracin-alginates oligomer conjugate
KR102016002B1 (en) * 2019-05-02 2019-08-29 주식회사 아이엘바이오 Cosmetic composition for improving skin-whitening, anti-wrinkle and head skin
CN110638673A (en) * 2019-09-25 2020-01-03 河北瑞龙生物科技有限公司 Skin care product containing green tea extract and preparation method thereof
CN112494409A (en) * 2020-12-31 2021-03-16 中华全国供销合作总社南京野生植物综合利用研究所 Onion extract fermentation product and application thereof in daily chemical products
CN115317417A (en) * 2022-07-20 2022-11-11 诺德溯源(广州)生物科技有限公司 Composition containing guaiacum extract for repairing acne sensitive muscle and skin care product thereof
CN115581656A (en) * 2022-09-22 2023-01-10 羽楠(广州)化妆品有限公司 Marine organism combination-based emotion awakening iceberg gel with soothing and repairing effects and preparation method thereof
CN115869233A (en) * 2023-01-09 2023-03-31 广州旭妆生物科技有限公司 Whitening and anti-wrinkle essence and preparation method thereof

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007075425A (en) * 2005-09-15 2007-03-29 Mochida Pharmaceut Co Ltd Wound covering material including alginic acid
US20070231417A1 (en) * 2006-03-09 2007-10-04 Gundula Geske Use of guaiac wood for treating inflammation of the skin
US20080153776A1 (en) * 2006-12-21 2008-06-26 Erning Xia Method of Treating Inflammation of the Eye
KR20090060981A (en) * 2009-05-22 2009-06-15 김석 Tape of protecting ultraviolet rays
JP2015030713A (en) * 2013-08-06 2015-02-16 花精舎株式会社 Skin cosmetic comprising extract of male flower of reynoutria sachalinense
CN109862904A (en) * 2016-10-21 2019-06-07 阿尔吉法玛公司 Bacitracin-alginates oligomer conjugate
CN108066187A (en) * 2018-01-12 2018-05-25 广州赛莱拉干细胞科技股份有限公司 A kind of makeup remover and preparation method thereof
KR102016002B1 (en) * 2019-05-02 2019-08-29 주식회사 아이엘바이오 Cosmetic composition for improving skin-whitening, anti-wrinkle and head skin
CN110638673A (en) * 2019-09-25 2020-01-03 河北瑞龙生物科技有限公司 Skin care product containing green tea extract and preparation method thereof
CN112494409A (en) * 2020-12-31 2021-03-16 中华全国供销合作总社南京野生植物综合利用研究所 Onion extract fermentation product and application thereof in daily chemical products
CN115317417A (en) * 2022-07-20 2022-11-11 诺德溯源(广州)生物科技有限公司 Composition containing guaiacum extract for repairing acne sensitive muscle and skin care product thereof
CN115581656A (en) * 2022-09-22 2023-01-10 羽楠(广州)化妆品有限公司 Marine organism combination-based emotion awakening iceberg gel with soothing and repairing effects and preparation method thereof
CN115869233A (en) * 2023-01-09 2023-03-31 广州旭妆生物科技有限公司 Whitening and anti-wrinkle essence and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANGELO BERATTO-RAMOS, ET AL: "Selection criteria for high-value biomass: seasonal and morphological variation of polyphenolic content and antioxidant capacity in two brown macroalgae", JOURNAL OF APPLIED PHYCOLOGY, 9 June 2018 (2018-06-09), pages 1 - 12 *
孙平等: "《图解本草纲目五色蔬菜对症速查全书》", vol. 1, 28 February 2022, 江苏凤凰科学技术出版社, pages: 177 *
李子安等: "瘢痕的形成机制及天然产物对其治疗的研究进展", 《中国美容医学》, vol. 25, no. 7, 30 July 2016 (2016-07-30), pages 105 - 109 *
黄丽娃等: "《美容营养学》", vol. 1, 31 January 2018, 华中科技大学出版社, pages: 74 *

Also Published As

Publication number Publication date
CN117679350B (en) 2024-06-07

Similar Documents

Publication Publication Date Title
US10695284B2 (en) Skin external composition for skin moisturization containing red yeast rice extract
CN107595737B (en) Whitening and anti-wrinkle composition containing antrodia camphorata, essence containing composition and preparation method of essence
EP2859918B1 (en) Cosmetic composition containing fermented ginseng berry pleurotus ferulae product
CN111388346A (en) Freeze-dried powder live mask with vegetable protein and polypeptide formula and preparation method thereof
CN109330954B (en) Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor
EP1135103A1 (en) Use of plant extracts with an anti-radical-type action
KR102253095B1 (en) Cosmetic composition for improving acned skin, Manufacturing method thereof and functional cosmetics for improving acned skin containing the same
JP2011088845A (en) Involucrin expression inhibitor
CN113368018A (en) Anti-inflammatory acne-removing composition and preparation method thereof
CN115212133A (en) Freeze-dried powder solvent and preparation method and application thereof
CN111265441A (en) Composition capable of enhancing skin night repair and regeneration capacity and application thereof
CN108852969B (en) Anti-wrinkle anti-aging whitening mask and preparation method thereof
KR102606356B1 (en) Cosmetic composition for regenerating skin and improving skin wrinkle
KR101727788B1 (en) Sargassum thunbergii hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same
CN110801412B (en) Sebum bionic composition, application thereof and cosmetics
CN117679350B (en) Guaiac composition for removing acne marks and smoothing acne pits and application thereof
KR101803757B1 (en) Cosmetic composition containing natural complex fermented extracts
CN107802545A (en) A kind of anti-oxidant and lightening compositions and the skin care item containing said composition
KR101552472B1 (en) Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity
CN114767608B (en) Natural plant maintenance refreshing Yan Fupei skin care product raw material, preparation method and application thereof
CN110801516A (en) Eye nutrient spray liquid and preparation method thereof
KR100371504B1 (en) Cosmetics composition comprising extract powder with vitis vinifera l.fermented solution and having whitening and anti-wrinkle effect
JP2011088854A (en) Involucrin expression inhibitor
KR20220001590A (en) Cosmetic composition comprising Dendropanax morbifera Extract for improving acne skin
KR102468264B1 (en) topical herbal composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant